// App-Quantinova.ai

9554 : Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP).

Researchers

Presenter

  • Alexander Noor Shoushtari

Principal Investigators

  • Pedram Navid-Azarbaijani

  • Claire Frances Friedman

  • Katherine Panageas

  • Michael Andrew Postow

  • Margaret K. Callahan

  • Parisa Momtaz

  • Shonnette C. Campbell

  • Yelena Shames

  • Nana A. Prempeh-Keteku

  • Kasiemobi Nwaedozie

  • Jedd D. Wolchok

  • Paul B. Chapman

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02186249

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved